SYNTHESIS AND EVALUATION OF TASTE-MASKED IONIC LIQUID SALTS OF LORATADINE
Objective: To synthesize and evaluate taste-masked ionic liquid (IL) salts of loratadine.
Methods: In the present work, pharmaceutically active IL salts of loratadine using selected counter-ions were synthesized. The synthesized IL salts were characterized using melting point, Ultraviolet (UV) spectroscopy, Fourier Transform Infra-Red (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), and X-ray Diffraction (XRD). These salts were also evaluated for solubility, dissolution, and palatability studies.
Results: All synthesized IL salts of loratadine exhibited melting points below 100 °C. UV spectral data and FTIR data confirmed the formation of new salt forms with selected counter-ions. The absence of sharp melting point peaks during DSC studies revealed the amorphous nature of new salt forms. During XRD studies, loratadine-indomethacin IL salt yields completely amorphous compound while the intensity of characteristic peaks of loratadine was found to be reduced with other counter-ions. Solubility studies revealed that the solubility of loratadine is reduced from 35.85 mg/ml to 3.63 mg/ml, 15.39 mg/ml, 5.31 mg/ml, and 3.71 mg/ml in case of IL-1, IL-2, IL-3, and IL-4, respectively. Dissolution studies further confirmed this finding. Except for oleate, all the IL salts were found to be palatable by subjects with the score ranging from 2.5 to 2.8, which is the standard range for palatability.
Conclusion: Results obtained in the present work indicated that IL salts of loratadine can be synthesized successfully using selected counter-ions. This approach can be used to mask the bitter taste of pure loratadine and thus can be used for the development of drug products intended for children.
2. Torimoto T, Tsuda T, Okazaki K, Kuwabata S. New frontier in material science opened by ionic liquids. Adv Mater 2010;22:1196–221.
3. Rogers RD, Voth GA. Ionic liquids. Acc Chem Res 2007;40:1077–8.
4. Whitney L, Hough WL, Smiglak M, Rodr?guez H, Swatloski RP, Spear SK, et al. The third evolution of ionic liquids: Active pharmaceutical ingredients. New J Chem 2007;31:1429–36.
5. Feng R, Zhao D, Guo Y. Revisiting characteristics of ionic liquids: a review for further application development. J Environ 2010;1:95-104.
6. Berthod A, Carda Broach. Uses of ionic liquids in Analytical Chemistry. MCFA Annals 2004;3:20-7.
7. Martins MAP, Frizzo CP, Moreira DN, Zanatta N, Bonacorso HG. Ionic liquids in heterocyclic synthesis. Chem Rev 2008;108:2015-50.
8. Han X, Armstrong DW. Ionic liquids in separations. Acc Chem Res 2007;40:1079-86.
9. Arrahman A, Gahayati A, Rizky D, Muslimah S, Munim A. Application of imidazole-based ionic liquids in microwave-assisted extraction of trans-resveratrol from gnetum gnemon L. seeds. Int J Appl Pharm 2018;10:39-42.
10. Hough WL, Rogers RD. Ionic liquids then and now: from solvents to materials to active pharmaceutical ingredients. Bull Chem Soc Japan 2007;80:2262–9.
11. Hapiot P, Lagrost C. Electrochemical reactivity in room-temperature ionic liquids. Chem Rev 2008;108:2238-64.
12. MacFarlane DR, Forsyth M, Howlett PC, Pringle JM, Sun J, Annat G, et al. Ionic liquids in electrochemical devices and processes: managing interfacial electrochemistry. Acc Chem Res 2007;40:1165?73.
13. Ferraz R, Branco LC, Prudencio C, Noronha JP, Petrovski Z. Ionic liquids as active pharmaceutical ingredients. Chem Med Chem 2011;6:975-87.
14. Stoimenovski J, MacFarlane DR, Bica K, Rogers RD. Crystalline vs. Ionic liquid salt forms of active pharmaceutical ingredients: a position paper. Pharm Res 2010;27:521-6.
15. Hough Troutman WL, Smiglak M, Griffin S, Reichert WM, Mirska I, Jodynis Liebert J, et al. Ionic liquids with dual biological function: sweet and anti-microbial, hydrophobic quaternary ammonium-based salts. New J Chem 2009;33:26–33.
16. Claritin (Loratadine) drug information. Available from: https://www.rxlist.com/claritin-side-effects-drug-center.htm [Last accessed on 12 Dec 2018].
17. Claritin product monograph, Bayer Inc; 2018. Available from: https://www.bayer.ca/omr/online/claritin-pm-en.pdf [Last accessed on 03 Jan 2019].
18. Loratadine solution drug information. Available from: https://www.webmd.com/drugs/2/drug-73-6282/loratadine-oral/loratadine-liquid-oral/details [Last accessed on 12 Dec 2018]
19. Dagar A, Gudi S, Opawale, Foyeke, Inventors. Oral liquid loratadine formulations and methods, PCT/US2007/069360; 2017.
20. Ferraz R, Prudencio C, Vieira M, Fernandes R, Noronha JP. Ionic liquids synthesis–methodologies. Organic Chem Curr Res 2015;1:e139.
21. Zhang S, Lu X, Zhou Q, Li X, Zhang X, Li S. Ionic Liquids, physicochemical properties. 1st ed. Elsevier BV, Oxford UK; 2009.
22. Danielewicz D, Kmiotek M, Surma Slusarska B. Study of Ionic liquids UV-VIS and FTIR spectra before and after heating and spruce groundwood dissolution. Fibres Text Eas Eur 2019;27:118-23.
23. Pamela M Dean, Jennifer M Pringle, Douglas R. MacFarlane structural analysis of low melting organic salts: perspectives on ionic liquids. Phys Chem Chem Phys 2010;12:9144-53.
24. L Yu. Amorphous pharmaceutical solids preparation, characterization. Adv Drug Delivery Rev 2001;48:27–42.
25. Sharma S, Lewis S. Taste masking technologies: a review. Int J Pharm Pharm Sci 2010;2:6-13.
This work is licensed under a Creative Commons Attribution 4.0 International License.